Review links hearing aid devices with reduced cognitive decline
Dec 06, 2022
Further, the use of devices is linked to a 3% improvement in cognitive test scores in the short term.
More news for Tuesday, Dec. 6
By
Kimberly Bonvissuto
Dec 06, 2022
LeadingAge Minnesota Foundation invests $400,000 in 24 workforce grants … Merger targets strengthening assisted living … FCC opens applications for $5M internet pilot program for affordable senior...
More news for Friday, Dec. 2
By
Kimberly Bonvissuto
Dec 02, 2022
Bill targets reform of CMS drug coverage authority in wake of aducanumab decision … FCC moves to improve affordable connectivity program for HUD residents … Partnership launches cybersecurity hub,...
Subjective cognitive decline tied to incident dementia in Black, Latinx individuals
Dec 01, 2022
Subjective cognitive decline was associated with increased rates of incident dementia over time in the multiracial population, Latinx and non-Latinx Black individuals.
Memory care breakthrough, or yet another false alarm?
By
John O'Connor
Dec 01, 2022
This week’s Alzheimer’s revelation is a hopeful sign, but even under the best possible scenario, much work remains.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.
Progress made in Alzheimer’s research and lifestyle interventions, NIH says
By
Kimberly Bonvissuto
Nov 30, 2022
The burden of Alzheimer’s disease and related dementias is significant, according to the National Institutes of Health. But scientists have made progress in drug development, lifestyle interventions,...
More news for Wednesday, Nov. 30
By
Kimberly Bonvissuto
Nov 30, 2022
Resources empower older adults to plan for changes in driving, firearm use: study … 40% of older adult brains show signs of LATE dementia … Amazon launches Alexa Smart Properties for Senior Living...
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.